I'll leave the TA to the experts.
FA though is of interest atm.
I wanted to re-invest some trades into an Artemis stock (some may know I was majority CUE)
But the dipping MOG/MEO and stronger CUE sp made the assessment interesting.
MOG is cheap, but no cash means it will be raising and diluting a lot after Artemis#1.
(Needs $18millions for Artemis #2 & #3)
$18 million is a big dilution of its current market cap which is ~$50milliion.
1/3 the market cap of MEO is not a big enough discount
CUE has many diverse assets and is on track to net over $20million for this year.
But MEO got the nod.
MEO has a lower market cap atm
20% W.I. versus 15% W.I. in Artemis
The cash bonuses will generate considerably more cash than CUE will in production. The first bonus less risk.
CUE's production is projected to decline from 2010 to 2014 - so MEO should maintain the better cashflow.
This doesn't account for the $18million CUE has to find for #2 & #3 wells versus MEO's free carry.
Or the $7million reimbursement.
CUE's farmin with WPL for Caterina is promising but much further away than Artemis.
So,
When MEO was 55 cents and CUE 22 cents - it was easy to put most into CUE.
On today's share prices - the decision was just as easy imo.
- Forums
- ASX - By Stock
- MEO
- oversold list 1 week % price change up 5.36%
oversold list 1 week % price change up 5.36%, page-2
Featured News
Add MEO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online